Background: The ratios of basal cell carcinomas (BBC) to squamous cell carcinomas (SCC) and to malignant melanomas (MM) have changed over time in the white population throughout the world. Objective: To evaluate the incidence of skin cancers in the Mosan region and the Belgian Ardennes over the past 6 years. Results: In contrast with epidemiological data reported by the Belgian National Cancer Registry, cutaneous cancers are the commonest malignancies occurring in humans. At the present time, the ratio BCC:SCC roughly equals 4 to 1. When combined, the incidence of BCC and SCC is about 10 times greater than that of MM. Conclusion: The rate of detection of skin cancers does not always correlate with the rate of notification of a national registry.

1.
Scotto J, Kopf AW, Urbach F: Non-melanoma skin cancers among Caucasians in four areas of the United States. Cancer 1974;34:1333–1338.
2.
Preston DS, Stern RS: Nonmelanoma cancers of the skin. N Engl J Med 1992;327:1649– 1662.
3.
Gloster HM, Brodland DG: The epidemiology of skin cancer. Dermatol Surg 1996;22:217– 226.
4.
Giles G, Marks R, Foley P: Incidence of nonmelanocytic skin cancer treated in Australia. Br Med J 1988;269:13–17.
5.
Glass AG, Hoover RN: The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097–2100.
6.
Weinstock MA: The epidemic of squamous cell carcinoma. JAMA 1989;262:2138–2140.
7.
Green A: Changing patterns in incidence of nonmelanoma skin cancer. Epithelial Cell Biol 1992;1:47–51.
8.
Lee JA: Trends in melanoma incidence and mortality. Clin Dermatol 1992;10:9–13.
9.
Marks R, Staples M, Giles GG: Trends in non-melanocytic skin cancer treated in Australia: The second national survey. Int J Cancer 1993; 53:585–590.
10.
Garbe C, Büttner P, Ellwanger U, Orfanos CE: Das Zentralregister Malignes Melanom der Deutschen Dermatologischen Gesellschaft in den Jahren 1983–1993: Epidemiologische Entwicklungen und Aktuelle Therapeutische Versorgung des Malignen Melanoms der Haut. Hautarzt 1995;46:683–692.
11.
Berg P, Lindelof B: Differences in malignant melanoma between children and adolescents. A 35-year epidemiological study. Arch Dermatol 1997;133:295–297.
12.
Gray DT, Suman VJ, Su WPD, Clay RP, Harmsen WS, Roenigk RK: Trends in the population-based incidence of squamous cell carcinoma of the skin first diagnosed between 1984 and 1992. Arch Dermatol 1997;133:735–740.
13.
Marks R: Epidemiology of non-melanoma skin cancer and solar keratoses in Australia: A tale of self-immolation in Elysian fields. Aust J Dermatol 1997;38:S26–S29.
14.
Haelterman M: Cancer in Belgium 1990–1992. Registre National du Cancer. Brussels 1992, pp 1–52.
15.
Piérard GE: A propos de l’incidence du mélanome malin dans la région mosane de la province de Liège. Nouv Dermatol 1985;4:163– 164.
16.
Pièrard GE: The Mosan study group of pigmented neoplasms. Dermatologica 1988;176: 124–129.
17.
Piérard-Franchimont C, Piérard GE: Rates of epidermal carcinomas in the Mosan region of Belgium. Dermatologica 1988;177:76–81.
18.
Piérard-Franchimont C, Burg G, Grosshans E, Kerl H, Piérard GE: Prévalence des cancers de la peau en région mosane et dans des pays européens de même latitude. Rev Méd Liège 1989;44:541–545.
19.
Piérard-Franchimont C, Piérard GE: Tumeurs cutanées fréquentes en gériatrie. Rev Méd Liège 1997;52:289–295.
20.
Waterhouse J, Muir C, Correa P, et al: Cancer Incidence in Five Continents. Oxford, Oxford University Press, 1976, vol 3.
21.
National Cancer Institute: SEER Program. Cancer Facts and Figures – US Department of Health and Human Services, Public Health Service. Bethesda, National Institutes of Health, 1993.
22.
Van der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, Briggs J, Cooke RA, Dempster AG, Essex WB: Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991;47:483–489.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.